Afinitor and Death - a phase IV clinical study of FDA data

Summary:

Death is found among people who take Afinitor, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.

The phase IV clinical study is created by eHealthMe based on reports of 39,807 people who have side effects when taking Afinitor from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 17, 2023

39,807 people reported to have side effects when taking Afinitor.
Among them, 5,716 people (14.36%) died.

What is Afinitor?

Afinitor has active ingredients of everolimus. It is often used in breast cancer metastatic. eHealthMe is studying from 39,878 Afinitor users for its effectiveness, alternative drugs and more.

Number of Afinitor and Death reports submitted per year:

* Approximation only. Some reports may have incomplete information.

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Expand to all the drugs that have ingredients of everolimus:

Death and drugs with ingredients of everolimus (6,365 reports)

Alternative drugs to, pros and cons of Afinitor:

Afinitor (39,878 reports)

Common Afinitor side effects:

Death: 5,716 reports
Fatigue (feeling of tiredness): 4,180 reports
Diarrhea: 3,836 reports
Breathing difficulty: 2,776 reports
Rashes (redness): 2,725 reports
Pneumonia: 2,409 reports

Browse all side effects of Afinitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

COVID vaccines that are related to Death:

Common drugs associated with Death:

All the drugs that are associated with Death:

Death (4,484 drugs)

Common conditions associated with Death:

Multiple myeloma: 23,142 reports
Pain: 20,012 reports
Primary pulmonary hypertension: 17,771 reports

All the conditions that are associated with Death:

Death (3,693 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on everolimus (the active ingredients of Afinitor) and Afinitor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.